ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 19 Jan 2015
Last Applicant/ Owned by
345 Park Avenue
New York
NY
10154
Serial Number
86000284 filed on 02th Jul 2013
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
NIMLAMBA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, name Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Mark Details
Serial Number
No 86000284
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Jan 2015 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 19th Jan 2015 | ABANDONMENT - NO USE STATEMENT FILED |
| 17th Jun 2014 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 22nd Apr 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 22nd Apr 2014 | PUBLISHED FOR OPPOSITION |
| 02th Apr 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 14th Mar 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 14th Mar 2014 | ASSIGNED TO LIE |
| 26th Feb 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 21st Feb 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |